9-hydroxy-10,12-octadecadienoic acid has been researched along with darglitazone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohlsson, BG; Pettersson, S; Salomonsson, L; Svensson, L; Wiklund, O | 1 |
1 other study(ies) available for 9-hydroxy-10,12-octadecadienoic acid and darglitazone
Article | Year |
---|---|
Oxidised LDL decreases VEGFR-1 expression in human monocyte-derived macrophages.
Topics: Activating Transcription Factors; Blood Proteins; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Data Interpretation, Statistical; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Linoleic Acids, Conjugated; Lipoproteins, LDL; Macrophages; Monocytes; Oxidation-Reduction; Proteins; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Transcription Factor AP-1; Transcription Factors; Vascular Endothelial Growth Factor Receptor-1 | 2003 |